Back to top
more

Aurora Cannabis (ACB)

(Real Time Quote from BATS)

$0.69 USD

0.69
730,745

-0.02 (-2.25%)

Updated Mar 24, 2023 11:15 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.52%
2Buy18.26%
3Hold9.60%
4Sell5.38%
5Strong Sell2.61%
S&P50010.68%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value A Growth B Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 38% (154 out of 250)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Trades from $1

Brokerage Reports

Research for ACB

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

0 items in cart

Aurora Cannabis Inc. [ACB]

Reports for Purchase

Showing records 1 - 20 ( 34 total )

Company: Aurora Cannabis Inc.

Industry: Medical - Products

Record: 1

02/10/2023

Industry Report

Pages: 17

Cannabis Market Highlights

Provider: Echelon Welath Partners

Analyst: SEMPLE A

Price: 25.00

Research Provided by a Third Party

Company: Aurora Cannabis Inc.

Industry: Medical - Products

Record: 2

06/27/2022

Industry Report

Pages: 10

Weekly ReHash: California at Inflection on Easing Regulations & Improved Access

Provider: Roth Capital Partners, Inc.

Analyst: FORTUNE S

Price: 12.50

Research Provided by a Third Party

Company: Aurora Cannabis Inc.

Industry: Medical - Products

Record: 3

05/06/2022

Industry Report

Pages: 7

Weekly ReHash: Early Readthrough Into 1Q22 Confirms Industry Headwinds

Provider: Roth Capital Partners, Inc.

Analyst: FORTUNE S

Price: 12.50

Research Provided by a Third Party

Company: Aurora Cannabis Inc.

Industry: Medical - Products

Record: 4

03/04/2022

Daily Note

Pages: 6

Research Summary

Provider: KEYBANC CAPITAL MARKETS

Analyst: Research Department

Price: 12.50

Research Provided by a Third Party

Company: Aurora Cannabis Inc.

Industry: Medical - Products

Record: 5

02/22/2022

Industry Report

Pages: 8

Weekly ReHash: Israel - Pioneering Cannabis into a Large Market Opportunity

Provider: Roth Capital Partners, Inc.

Analyst: FORTUNE S

Price: 12.50

Research Provided by a Third Party

Company: Aurora Cannabis Inc.

Industry: Medical - Products

Record: 6

02/11/2022

Industry Report

Pages: 8

Weekly ReHash: Cannabis SPACs Underperformed in 2021, Reset

Provider: Roth Capital Partners, Inc.

Analyst: FORTUNE S

Price: 12.50

Research Provided by a Third Party

Company: Aurora Cannabis Inc.

Industry: Medical - Products

Record: 7

02/11/2022

Industry Report

Pages: 18

Cannabis Market Highlights

Provider: Echelon Welath Partners

Analyst: SEMPLE A

Price: 25.00

Research Provided by a Third Party

Company: Aurora Cannabis Inc.

Industry: Medical - Products

Record: 8

10/25/2021

Industry Report

Pages: 9

Weekly ReHash: MJBiz Takeaway Points Toward M&A in a Status Quo Environment

Provider: Roth Capital Partners, Inc.

Analyst: FORTUNE S

Price: 12.50

Research Provided by a Third Party

Company: Aurora Cannabis Inc.

Industry: Medical - Products

Record: 9

10/18/2021

Industry Report

Pages: 7

Weekly ReHash: Federal Legislation Should Start Heating Up

Provider: Roth Capital Partners, Inc.

Analyst: FORTUNE S

Price: 12.50

Research Provided by a Third Party

Company: Aurora Cannabis Inc.

Industry: Medical - Products

Record: 10

09/28/2021

Company Report

Pages: 10

ValuEngine Detailed Valuation Report for ACB

Provider: ValuEngine, Inc

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Aurora Cannabis Inc.

Industry: Medical - Products

Record: 11

09/11/2021

Industry Report

Pages: 6

Weekly ReHash: Brands Focus on Deck

Provider: Roth Capital Partners, Inc.

Analyst: FORTUNE S

Price: 25.00

Research Provided by a Third Party

Company: Aurora Cannabis Inc.

Industry: Medical - Products

Record: 12

09/03/2021

Industry Report

Pages: 7

Weekly ReHash: CAOA Feedback, Fall Potential Legislation Passage In Budget Bill

Provider: Roth Capital Partners, Inc.

Analyst: FORTUNE S

Price: 25.00

Research Provided by a Third Party

Company: Aurora Cannabis Inc.

Industry: Medical - Products

Record: 13

08/30/2021

Industry Report

Pages: 8

Weekly ReHash: Ranking 2Q Earnings Reports, Well Capitalized MSOs

Provider: Roth Capital Partners, Inc.

Analyst: FORTUNE S

Price: 25.00

Research Provided by a Third Party

Company: Aurora Cannabis Inc.

Industry: Medical - Products

Record: 14

07/19/2021

Industry Report

Pages: 6

A Day of Progress for Cannabis Legislative Reform

Provider: Roth Capital Partners, Inc.

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Aurora Cannabis Inc.

Industry: Medical - Products

Record: 15

07/12/2021

Industry Report

Pages: 8

Expectations of Schumer''s Legalization Plan

Provider: Roth Capital Partners, Inc.

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Aurora Cannabis Inc.

Industry: Medical - Products

Record: 16

06/18/2021

Industry Report

Pages: 8

Weekly ReHash: 50th Anniversary of Cannabis Prohibition, Conversion Takes Time

Provider: Roth Capital Partners, Inc.

Analyst: FORTUNE S

Price: 25.00

Research Provided by a Third Party

Company: Aurora Cannabis Inc.

Industry: Medical - Products

Record: 17

05/17/2021

Industry Report

Pages: 56

Weekly Comp

Provider: Beacon Securities Ltd.

Analyst: COOPER D

Price: 100.00

Research Provided by a Third Party

Company: Aurora Cannabis Inc.

Industry: Medical - Products

Record: 18

01/13/2021

Daily Note

Pages: 13

4Q20 Industrial Earnings Preview

Provider: KEYBANC CAPITAL MARKETS

Analyst: HAMMOND J

Price: 50.00

Research Provided by a Third Party

Company: Aurora Cannabis Inc.

Industry: Medical - Products

Record: 19

11/09/2020

Company Report

Pages: 6

Opex in Range, Margin Upturn Next

Provider: PI Financial Corp.

Analyst: ZANDBERG J

Price: 25.00

Research Provided by a Third Party

Company: Aurora Cannabis Inc.

Industry: Medical - Products

Record: 20

09/23/2020

Company Report

Pages: 6

New Stated Focus on Premium Products

Provider: PI Financial Corp.

Analyst: ZANDBERG J

Price: 25.00

Research Provided by a Third Party